Company / Working Capital per Share
Anixa Biosciences Inc Working Capital per Share History
FY2014-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.61
FY2024
5-year range
$0.24 / $0.94
FY2020-FY2024
Trend
-19.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has fluctuated over the past 10 years, ranging from $0.02 in FY2014 to $0.94 in FY2022.
Based on SEC 10-K filings.
0.61 in FY2024 with a 10-year CAGR of +39.6%.
Declined from $0.94 to $0.61 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +19.9%
- 10-Year CAGR
- +39.6%
Key checks
Key Insights
- In FY2024, working capital per share decreased 19.7% year-over-year.
- Peak working capital per share was recorded in FY2022.
- Lowest working capital per share in the period was in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.61 | -19.7% |
| FY2023 | $0.75 | -19.5% |
| FY2022 | $0.94 | +132.9% |
| FY2020 | $0.40 | +65.0% |
| FY2019 | $0.24 | -5.2% |
| FY2018 | $0.26 | -63.2% |
| FY2017 | $0.70 | +108.3% |
| FY2016 | $0.34 | -53.1% |
| FY2015 | $0.72 | +3225.8% |
| FY2014 | $0.02 | +521.8% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026